Validation of the male osteoporosis risk estimation score (MORES) in a primary care setting

Alvah R. Cass, Angela Shepherd

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Primary care physicians are positioned to promote early recognition and treatment of men at risk for osteoporosis-related fractures; however, efficient screening strategies are needed. This study was designed to validate the Male Osteoporosis Risk Estimation Score (MORES) for identifying men at increased risk of osteoporosis. Methods: This was a blinded analysis of the MORES, administered prospectively in a cross-sectional sample of men aged 60 years or older. Participants completed a research questionnaire at an outpatient visit and had a dual-energy X-ray absorptiometry (DXA) scan to assess bone density. Sensitivity, specificity, and area under-the-curve (AUC) were estimated for the MORES. Effectiveness was assessed by the number needed-to-screen (NNS) to prevent one additional major osteoporotic fracture. Results: A total of 346 men completed the study. The mean age was 70.2 ± 6.9 years; 76% were non- Hispanic white. Fifteen men (4.3%) had osteoporosis of the hip. The operating characteristics were sensitivity 0.80 (95% confidence interval [CI], 0.52- 0.96); specificity 0.70 (95% CI, 0.64-0.74), and AUC of 0.82 (95% CI, 0.71- 0.92). Screening with the MORES yielded a NNS to prevent one additional major osteoporotic fracture over 10 years with 259 (95% CI, 192-449) compared to 636 for universal screening with a DXA. Conclusion: This study validated the MORES as an effective and efficient approach to identifying men at increased risk of osteoporosis who may benefit from a diagnostic DXA scan. (J Am Board Fam Med 2013;26:436-444.).

Original languageEnglish (US)
Pages (from-to)436-444
Number of pages9
JournalJournal of the American Board of Family Medicine
Volume26
Issue number4
DOIs
StatePublished - Jul 2013

Fingerprint

Osteoporosis
Primary Health Care
Photon Absorptiometry
Confidence Intervals
Osteoporotic Fractures
Area Under Curve
Primary Care Physicians
Hispanic Americans
Bone Density
Hip
Outpatients
Sensitivity and Specificity
Research

Keywords

  • Decision making
  • Men's health
  • Osteoporosis
  • Prevention
  • Primary health care
  • Screening

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

Validation of the male osteoporosis risk estimation score (MORES) in a primary care setting. / Cass, Alvah R.; Shepherd, Angela.

In: Journal of the American Board of Family Medicine, Vol. 26, No. 4, 07.2013, p. 436-444.

Research output: Contribution to journalArticle

@article{73dc0c1ff4f945509439676d263406a0,
title = "Validation of the male osteoporosis risk estimation score (MORES) in a primary care setting",
abstract = "Background: Primary care physicians are positioned to promote early recognition and treatment of men at risk for osteoporosis-related fractures; however, efficient screening strategies are needed. This study was designed to validate the Male Osteoporosis Risk Estimation Score (MORES) for identifying men at increased risk of osteoporosis. Methods: This was a blinded analysis of the MORES, administered prospectively in a cross-sectional sample of men aged 60 years or older. Participants completed a research questionnaire at an outpatient visit and had a dual-energy X-ray absorptiometry (DXA) scan to assess bone density. Sensitivity, specificity, and area under-the-curve (AUC) were estimated for the MORES. Effectiveness was assessed by the number needed-to-screen (NNS) to prevent one additional major osteoporotic fracture. Results: A total of 346 men completed the study. The mean age was 70.2 ± 6.9 years; 76{\%} were non- Hispanic white. Fifteen men (4.3{\%}) had osteoporosis of the hip. The operating characteristics were sensitivity 0.80 (95{\%} confidence interval [CI], 0.52- 0.96); specificity 0.70 (95{\%} CI, 0.64-0.74), and AUC of 0.82 (95{\%} CI, 0.71- 0.92). Screening with the MORES yielded a NNS to prevent one additional major osteoporotic fracture over 10 years with 259 (95{\%} CI, 192-449) compared to 636 for universal screening with a DXA. Conclusion: This study validated the MORES as an effective and efficient approach to identifying men at increased risk of osteoporosis who may benefit from a diagnostic DXA scan. (J Am Board Fam Med 2013;26:436-444.).",
keywords = "Decision making, Men's health, Osteoporosis, Prevention, Primary health care, Screening",
author = "Cass, {Alvah R.} and Angela Shepherd",
year = "2013",
month = "7",
doi = "10.3122/jabfm.2013.04.120182",
language = "English (US)",
volume = "26",
pages = "436--444",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "4",

}

TY - JOUR

T1 - Validation of the male osteoporosis risk estimation score (MORES) in a primary care setting

AU - Cass, Alvah R.

AU - Shepherd, Angela

PY - 2013/7

Y1 - 2013/7

N2 - Background: Primary care physicians are positioned to promote early recognition and treatment of men at risk for osteoporosis-related fractures; however, efficient screening strategies are needed. This study was designed to validate the Male Osteoporosis Risk Estimation Score (MORES) for identifying men at increased risk of osteoporosis. Methods: This was a blinded analysis of the MORES, administered prospectively in a cross-sectional sample of men aged 60 years or older. Participants completed a research questionnaire at an outpatient visit and had a dual-energy X-ray absorptiometry (DXA) scan to assess bone density. Sensitivity, specificity, and area under-the-curve (AUC) were estimated for the MORES. Effectiveness was assessed by the number needed-to-screen (NNS) to prevent one additional major osteoporotic fracture. Results: A total of 346 men completed the study. The mean age was 70.2 ± 6.9 years; 76% were non- Hispanic white. Fifteen men (4.3%) had osteoporosis of the hip. The operating characteristics were sensitivity 0.80 (95% confidence interval [CI], 0.52- 0.96); specificity 0.70 (95% CI, 0.64-0.74), and AUC of 0.82 (95% CI, 0.71- 0.92). Screening with the MORES yielded a NNS to prevent one additional major osteoporotic fracture over 10 years with 259 (95% CI, 192-449) compared to 636 for universal screening with a DXA. Conclusion: This study validated the MORES as an effective and efficient approach to identifying men at increased risk of osteoporosis who may benefit from a diagnostic DXA scan. (J Am Board Fam Med 2013;26:436-444.).

AB - Background: Primary care physicians are positioned to promote early recognition and treatment of men at risk for osteoporosis-related fractures; however, efficient screening strategies are needed. This study was designed to validate the Male Osteoporosis Risk Estimation Score (MORES) for identifying men at increased risk of osteoporosis. Methods: This was a blinded analysis of the MORES, administered prospectively in a cross-sectional sample of men aged 60 years or older. Participants completed a research questionnaire at an outpatient visit and had a dual-energy X-ray absorptiometry (DXA) scan to assess bone density. Sensitivity, specificity, and area under-the-curve (AUC) were estimated for the MORES. Effectiveness was assessed by the number needed-to-screen (NNS) to prevent one additional major osteoporotic fracture. Results: A total of 346 men completed the study. The mean age was 70.2 ± 6.9 years; 76% were non- Hispanic white. Fifteen men (4.3%) had osteoporosis of the hip. The operating characteristics were sensitivity 0.80 (95% confidence interval [CI], 0.52- 0.96); specificity 0.70 (95% CI, 0.64-0.74), and AUC of 0.82 (95% CI, 0.71- 0.92). Screening with the MORES yielded a NNS to prevent one additional major osteoporotic fracture over 10 years with 259 (95% CI, 192-449) compared to 636 for universal screening with a DXA. Conclusion: This study validated the MORES as an effective and efficient approach to identifying men at increased risk of osteoporosis who may benefit from a diagnostic DXA scan. (J Am Board Fam Med 2013;26:436-444.).

KW - Decision making

KW - Men's health

KW - Osteoporosis

KW - Prevention

KW - Primary health care

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84880980341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880980341&partnerID=8YFLogxK

U2 - 10.3122/jabfm.2013.04.120182

DO - 10.3122/jabfm.2013.04.120182

M3 - Article

VL - 26

SP - 436

EP - 444

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 4

ER -